Sofinnova
Sofinnova holds EUR 150m close for third biotech fund
Impact fund has made two investments as of its interim close and expects to make 10-12 in total
Consortium backs €38.75m series-B for Tissium
France-based wound dressing developer previously raised €30.5m at the series-A stage
French GPs opt for organic diversification
Recent fund closes show that organic diversification is still a valid option for some GPs and VCs willing to step out of their comfort zones
Sofinnova et al. invest €20m in Afyren
France-based biotech business Afyren plans to commercialise its products in 2020
Sofinnova et al. back €27m series-C for Limflow
BPI France and Balestier, a Singaporean family fund, also take part in the financing
Sofinnova closes biotech fund on $650m hard-cap
Fund's different generations have received a combined $2bn of committments in total
Sofinnova leads €22.5m Gecko Biomedical round
Extension to series-A round also includes BPI France, Omnes, CM-CIC Innovation and CapDecisif
Sofinnova and Imperial's Mission Therapeutics raises £60m
Investment led by Woodford Patient Capital Trust and saw existing backers re-up
Sofinnova et al. in €72.8m series-C round for Merus
Third largest round observed by unquote" in Benelux so far in 2015
VC backers divest GlycoVaxyn to GSK
Deal values biopharmaceutical company at $212m
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round
Auris' delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
VC-backed OpenERP raises $10m
Company to rebrand as Odoo as part of the deal
Sofinnova leads CHF 32m round for ObsEva
Sofinnova Partners has led a CHF 32m series-A round for Swiss biopharma company ObsEva.
European venture: patience rewarded
Patience rewarded
Idinvest leads €34m round for Crocus
Idinvest Partners has led a €34m funding round for Crocus Technology, a French supplier of magnetic semiconductors and sensors, with participation from a consortium of new and existing backers.
Emerald Technology Ventures et al. back MetGen
Emerald Technology Ventures and several other backers have invested in a series-A financing round for MetGen Oy, a Finnish industrial biotech company.
CDC Entreprises and Sofinnova invest €8m in MedDay
CDC Entreprises and Sofinnova Partners have made an €8m equity investment in French biotech firm MedDay.
Aledia raises €10m in first funding round
Sofinnova Partners, Braemar Energy Ventures, Demeter Partners and CEA Investissement have participated in a €10m funding round for French LED developer Aledia.
CDC leads €10m round for McPhy Energy
CDC Entreprises has invested €5m as part of a €10m round for French hydrogen storage specialist McPhy Energy.
Declining activity belies venture successes
Although European venture capital activity decreased by 12% to €974m last year, 2011 saw a number of sizeable fund closes as well strong exits, indicating fresh appetite for the asset class.
Sofinnova promotes two team members
Venture firm Sofinnova Partners has promoted Rafaèle Tordjman from partner to managing partner and Alessio Beverina from principal to partner.